Clinical Trials Logo

Influenza Epidemic clinical trials

View clinical trials related to Influenza Epidemic.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06385821 Completed - Influenza Clinical Trials

A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Start date: September 21, 2022
Phase: Phase 3
Study type: Interventional

The goal of this clinical study is to prove the no less immunogenicity of the Grippol Quadrivalent vaccine compared to the Grippol plus vaccine in children aged 6 months to 5 years (inclusive) for three identical strains of the compared vaccines in terms of the "proportion of vaccinated with seroconversion in paired sera of the hemagglutination inhibition reaction obtained before and after vaccination".

NCT ID: NCT03651544 Completed - Influenza A Clinical Trials

The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

Start date: October 15, 2018
Phase: Phase 1
Study type: Interventional

The present clinical phase I study designed to examine the safety, reactogenicity and immunogenicity of the medicinal product - Vaccine vector against influenza A - in healthy volunteers after a single dose in the three groups with dose escalation.